ReviewDrug safety2025

Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases.

Jasmine Amirzadegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.